Adipose tissues, which serve as fat reserves, have been recognised as an endocrine organ. The three-dimensional (3D) bio...
Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...
South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
Olympus Corporation of Asia Pacific (APAC) has announced a milestone for its iTind device with expanded availability acr...
A Leading Center for Biopharma Excellence BIX has established itself as a must-attend event for professionals across th...
The future of biopharmaceutical innovation will take centr- stage at BIOPLUS-INTERPHEX KOREA (BIX) 2025, returning on Oc...
China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...
The International Vaccine Institute (IVI) has opened its new Biorepository, a global centre for biological resources, at...
South Korea-based Coreline Soft, a global leader in artificial intelligence (AI)-based medical solutions, has annou...
Brexogen, a leading biotechnology company specialising in exosome-based therapeutics, has announced a technology transfe...
Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and small to mi...
Taiwan-based startup Health2Sync, a leading provider of digital therapeutics solutions for chronic diseases, is experien...
SK Bioscience reported strong revenue growth in Q4 2024, primarily driven by the consolidation of IDT Biologika, expansi...
South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...
South Korea-based SK bioscience has announced that it is the only private company to participate in the World Health Org...
Daewoong Pharmaceutical, a leading healthcare company in Korea, has announced the official launch of its high-purity, hi...
South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...
